Indapyrophenidone

Indapyrophenidone is a psychoactive drug and research chemical that belongs to the phenidone class. It is structurally related to pyrovalerone, a stimulant drug that was formerly used in the treatment of chronic fatigue and as an appetite suppressant, but is now largely obsolete due to concerns about its potential for abuse.

History

Indapyrophenidone was first synthesized in the late 20th century as part of a series of phenidone derivatives. However, it did not enter widespread use until the 21st century, when it began to be sold online as a designer drug and research chemical.

Pharmacology

Like other phenidone derivatives, indapyrophenidone is believed to act as a norepinephrine-dopamine reuptake inhibitor (NDRI), blocking the reuptake of these neurotransmitters and thereby increasing their levels in the brain. This can result in effects such as increased alertness, euphoria, and increased physical activity.

Legal status

The legal status of indapyrophenidone varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and addiction. In others, it is legal to possess and use for research purposes, but not for human consumption.

Health effects

The health effects of indapyrophenidone are not well-studied, due to its relatively recent emergence and low prevalence of use. However, like other stimulant drugs, it is likely to carry risks of cardiovascular disease, psychosis, and addiction. Users may also experience side effects such as insomnia, anxiety, and loss of appetite.

See also

• Phenidone
• Pyrovalerone
• Research chemical
• Designer drug